Our findings are in contrast with those reported by Bray et al., in which they showed significant synergy between chloroquine (CQ) and the mTOR inhibitor CCI-779 in several different RCC cell lines [34]. This evidence concerns the gene MTOR and renal cell adenocarcinoma.